The Pharma Data

DECEMBER 17, 2020

Goater is CEO at Surface Oncology, an immuno-oncology company developing next-generation antibody therapies. Prior to joining Clarify, Gulati was a partner at McKinsey and Company, working with the Life Science, Medical Products and Health Systems practices in the US and EMEA.

Development 52

Development Gene Therapy Engineer Life Science 52

Delveinsight

JULY 21, 2021

The prevalence is rising at a significant pace at par with heart disease and cancer and mounting a significant burden on the healthcare infrastructure and the degraded quality of life to the affected population. However, some of the key pharma companies at the global level have shifted their focus towards these diverse diseases.

Pharma Companies 94

Pharma Companies Marketing Development Insulin 94

pharmaphorum

APRIL 7, 2021

While the Darzalex revenues are due to fall this year because of Janssen’s interpretation of the agreement between the two companies, there are also other revenue streams. With other drugs in the pipeline too, van de Winkel said the company aims to continue to break new ground with next-generation antibody-based therapies.

Antibody 91

Antibody Life Science Development Drugs 91

pharmaphorum

MARCH 9, 2021

Last year, Belgium’s ExeVir Bio raised 23 million euros ($27 million) to finance development of llama antibodies – and now it is ready to begin clinical development of a potential treatment that could be effective against emerging COVID-19 variants. ExeVir is not the first company to spin out of VIB to focus on camelid antibodies.

Antibody 98

Antibody Life Science Scientist Development 98

pharmaphorum

DECEMBER 23, 2020

It has been a year dominated by the pandemic and many life sciences research projects were put on hold as big pharma turned its attention to vaccines and therapies. Pharma companies have also made headway in rare diseases as several pipeline projects came to fruition. Rare disease progress.

Marketing 96

Marketing Gene Gene Silencing Drugs 96

XTalks

MAY 13, 2021

Here are the top three pharma ads from the past seven days. Novo Nordisk’s oral GLP-1 diabetes drug Rybelsus (semaglutide) has been up in the ranks this year in pharma TV ad spending, with the Danish pharma company having spent $19.9 The antibody is an IL-4 receptor alpha (IL-4R?) 1. Rybelsus. million and $18.6

Insulin 104

Insulin Marketing Drugs Branding 104

XTalks

MAY 25, 2021

Biosimilar and interchangeable products can expand treatment options and lower drug and healthcare costs by offering a cheaper alternative with the same effectiveness; essentially a non-branded version of a biologic such as monoclonal antibodies, proteins and vaccines. million in 2019, according to Fortune Business Insights.

Production 98

Production Drugs Marketing Sales 98

XTalks

OCTOBER 22, 2020

In this sense, pharmaceutical companies have developed different strategies to produce a wide variety of advanced therapy medicinal products (ATMP) and biological products, such as monoclonal antibodies, recombinant proteins, gene therapy viral vectors, CAR-T cells and oncolytic viruses, in order to deliver new medical needs in our society.

Manufacturing 98

Manufacturing Development Production Gene Therapy 98

Pharmaceutical Technology

APRIL 24, 2023

These attributes make some biologic drugs, especially monoclonal antibodies more specific and targeted in their treatment. With new drugs on the market, companies are now looking for ways to manufacture recently approved biologics, and countries are racing to claim their corner – or maintain their decades-old market share.

Contract Manufacturing 130

Contract Manufacturing Manufacturing Protein Sales 130

XTalks

JUNE 25, 2024

In the past two years, the industry has faced considerable challenges due to a constrained financing environment, forcing many emerging and early-stage biotech companies to restructure their operations, merge with other companies or narrow their research and development (R&D) efforts by shelving certain assets. billion in 2023.

Pharma Companies 52

Pharma Companies Production FDA Approval Vaccination 52

XTalks

MAY 29, 2024

Here, we will deep-dive into the top five fastest growing pharma and biotech companies in 2024, showcasing their innovative strategies and inspiring achievements. Pfizer (Overall Rank 268) Leading the list is one of the most renowned pharma companies in the world: Pfizer.

Medicine 52

Medicine Marketing FDA Approval Development 52

pharmaphorum

SEPTEMBER 18, 2020

But although it was dubbed a “dangerous game”, some companies came out on top… On 6th April 1999, two companies with similar science-based cultures and a shared vision of the pharmaceutical industry came together to form what’s now considered as one of the top ten pharma companies in the world: AstraZeneca.

Pharma Companies 116

Pharma Companies Sales Vaccination Vaccine 116

pharmaphorum

APRIL 19, 2021

UK biotech guru Clive Dix has clinched some major deals with big pharma and biotech in the last 12 months, as CEO of C4X Discovery and as head of the UK vaccines taskforce. It’s been eventful 12-month period for the UK biotech guru Clive Dix, who has just seen his company C4X Discovery clinch a major inflammatory diseases deal with Sanofi.

Vaccination 98

Vaccination Vaccine Life Science Antibody 98

XTalks

AUGUST 17, 2020

Monoclonal antibodies : these are antibodies that are designed to bind to specific targets on cells. The design of the immune biologic puts these elements together on an antibody scaffold. With the Neo-STAT platform, “it’s like making a separate antibody molecule for each one of those. Immune system modulators (i.e.

Protein 98

Protein Engineer Immune Response In-Vivo 98

XTalks

MAY 29, 2024

The top ten pharma companies in 2023 by revenue accounted for about 35 percent of the market value, with total earnings of $559.5 The top big pharma players have remained relatively consistent in their market positions over the past several years. Here is a look at the top ten pharma companies in 2024 based on 2023 revenue.

Pharma Companies 52

Pharma Companies Sales FDA Approval Vaccination 52

XTalks

AUGUST 18, 2021

These samples are often made available to support the research efforts of pharma companies developing new antibacterial agents. Historically, the top 50 pharma companies by sales have been steadily ending their anti-infective, and in particular, their AMR drug development programs and have had little incentive to get back in the game.

Development 105

Development Bacteria Drugs Vaccination 105

XTalks

DECEMBER 30, 2024

Quality assurance (QA) plays a vital role across industries like life sciences, food, medical devices and healthcare. From life-saving drugs to ensuring the food we consume is safe, QAs impact is far-reaching. Background, Skills and Know-How A bachelors degree in law, life sciences or business is common.

Compliance 52

Compliance Engineer Life Science Manufacturing 52

XTalks

MARCH 11, 2025

Emerging evidence indicates that a multivalent mRNA vaccine encoding hemagglutinin antigens from all known influenza virus subtypes can elicit broad, cross-reactive antibody responses in animal models, demonstrating the potential of mRNA platforms to overcome challenges posed by antigenically variable viruses.

Vaccination 64

Vaccination Vaccine Development Manufacturing 64

Roots Analysis

JANUARY 27, 2025

It is important to note that, for the purpose of subcutaneous biologics market analysis, the biologics were segregated into antibodies , nucleotides, proteins and vaccines. Currently, antibodies segment is likely to occupy the largest share in the overall market. Further, majority of the approved subcutaneous biologics are proteins.

Marketing 40

Marketing Drug Delivery Development Protein 40

XTalks

FEBRUARY 11, 2025

billion in total sales for 2022, the most ever reported by any pharma company in a single year. In 2010, the FDA approved PCV13 for children, extending protection to six additional serotypes by stimulating the bodys production of antibodies, similar to the response seen with PCV7. The following year saw sales edge up to $37.8

Sales 66

Sales FDA Approval Vaccination Vaccine 66